XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 154 filers reported holding XENON PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,305,833 | +5.0% | 243,145 | +18.3% | 0.00% | 0.0% |
Q2 2023 | $7,913,137 | -9.0% | 205,536 | -15.4% | 0.00% | 0.0% |
Q1 2023 | $8,696,290 | +150.2% | 242,981 | +175.7% | 0.00% | – |
Q4 2022 | $3,475,125 | -39.2% | 88,134 | -44.4% | 0.00% | -100.0% |
Q3 2022 | $5,720,000 | -81.2% | 158,452 | -84.1% | 0.00% | -75.0% |
Q2 2022 | $30,362,000 | -31.0% | 998,072 | -30.7% | 0.00% | -33.3% |
Q1 2022 | $44,026,000 | +61.6% | 1,440,171 | +65.1% | 0.01% | +100.0% |
Q4 2021 | $27,243,000 | +4272.9% | 872,084 | +2040.8% | 0.00% | – |
Q3 2021 | $623,000 | -36.4% | 40,736 | -22.6% | 0.00% | – |
Q2 2021 | $979,000 | +1000.0% | 52,600 | +960.7% | 0.00% | – |
Q1 2021 | $89,000 | +134.2% | 4,959 | +101.7% | 0.00% | – |
Q4 2020 | $38,000 | +40.7% | 2,459 | 0.0% | 0.00% | – |
Q3 2020 | $27,000 | -12.9% | 2,459 | -1.6% | 0.00% | – |
Q2 2020 | $31,000 | -50.0% | 2,499 | -54.1% | 0.00% | – |
Q1 2020 | $62,000 | +17.0% | 5,445 | +34.0% | 0.00% | – |
Q4 2019 | $53,000 | -24.3% | 4,062 | -47.3% | 0.00% | – |
Q3 2019 | $70,000 | +14.8% | 7,715 | +25.5% | 0.00% | – |
Q2 2019 | $61,000 | +24.5% | 6,148 | +25.3% | 0.00% | – |
Q1 2019 | $49,000 | -77.6% | 4,907 | -85.8% | 0.00% | – |
Q4 2018 | $219,000 | +90.4% | 34,676 | +297.5% | 0.00% | – |
Q3 2018 | $115,000 | +296.6% | 8,723 | +175.5% | 0.00% | – |
Q2 2018 | $29,000 | +262.5% | 3,166 | +91.1% | 0.00% | – |
Q1 2018 | $8,000 | -73.3% | 1,657 | -84.0% | 0.00% | – |
Q4 2017 | $30,000 | -88.4% | 10,325 | -87.4% | 0.00% | – |
Q2 2017 | $259,000 | +3137.5% | 82,242 | +3797.7% | 0.00% | – |
Q1 2017 | $8,000 | -55.6% | 2,110 | -7.1% | 0.00% | – |
Q4 2016 | $18,000 | -21.7% | 2,272 | -19.2% | 0.00% | – |
Q3 2016 | $23,000 | +360.0% | 2,811 | +206.5% | 0.00% | – |
Q2 2016 | $5,000 | -16.7% | 917 | 0.0% | 0.00% | – |
Q1 2016 | $6,000 | -14.3% | 917 | 0.0% | 0.00% | – |
Q4 2015 | $7,000 | -78.8% | 917 | -67.6% | 0.00% | – |
Q2 2015 | $33,000 | +560.0% | 2,829 | +773.1% | 0.00% | – |
Q1 2015 | $5,000 | – | 324 | +1308.7% | 0.00% | – |
Q4 2014 | $0 | – | 23 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 1,594,932 | $48,518,000 | 10.26% |
GREAT POINT PARTNERS LLC | 1,104,334 | $33,594,000 | 8.06% |
ACUTA CAPITAL PARTNERS, LLC | 272,500 | $8,289,000 | 4.62% |
DAFNA Capital Management LLC | 438,623 | $13,343,000 | 3.64% |
Parkman Healthcare Partners LLC | 294,559 | $8,960,000 | 3.30% |
Avoro Capital Advisors LLC | 4,900,000 | $149,058,000 | 2.94% |
Nan Fung Group Holdings Ltd | 114,380 | $3,479,000 | 2.39% |
BVF INC/IL | 1,597,966 | $48,610,000 | 2.35% |
SILVERARC CAPITAL MANAGEMENT, LLC | 232,630 | $7,077,000 | 2.18% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 4,391,038 | $133,575,000 | 2.16% |